Induction of antigen specific intrahepatic CD8+ T cell responses by a secreted heat shock protein based gp96-Ig-PfCA malaria vaccine

Front Immunol. 2023 Mar 28:14:1130054. doi: 10.3389/fimmu.2023.1130054. eCollection 2023.

Abstract

Introduction: A highly efficacious and durable vaccine against malaria is an essential tool for global malaria eradication. One of the promising strategies to develop such a vaccine is to induce robust CD8+ T cell mediated immunity against malaria liver-stage parasites.

Methods: Here we describe a novel malaria vaccine platform based on a secreted form of the heat shock protein, gp96-immunoglobulin, (gp96-Ig) to induce malaria antigen specific, memory CD8+ T cells. Gp96-Ig acts as an adjuvant to activate antigen presenting cells (APCs) and chaperone peptides/antigens to APCs for cross presentation to CD8+ T cells.

Results: Our study shows that vaccination of mice and rhesus monkeys with HEK-293 cells transfected with gp96-Ig and two well-known Plasmodium falciparum CSP and AMA1 (PfCA) vaccine candidate antigens, induces liver-infiltrating, antigen specific, memory CD8+ T cell responses. The majority of the intrahepatic CSP and AMA1 specific CD8+ T cells expressed CD69 and CXCR3, the hallmark of tissue resident memory T cells (Trm). Also, we found intrahepatic, antigen-specific memory CD8+ T cells secreting IL-2, which is relevant for maintenance of effective memory responses in the liver.

Discussion: Our novel gp96-Ig malaria vaccine strategy represents a unique approach to induce liver-homing, antigen-specific CD8+ T cells critical for Plasmodium liver-stage protection.

Keywords: Gp96; liver CD8+ T cells specific; malaria; memory; vaccine.

Publication types

  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Antigens, Protozoan
  • CD8-Positive T-Lymphocytes
  • HEK293 Cells
  • Heat-Shock Proteins / metabolism
  • Humans
  • Immunoglobulins / metabolism
  • Malaria Vaccines*
  • Malaria* / metabolism
  • Malaria* / prevention & control
  • Malaria, Falciparum*

Substances

  • Malaria Vaccines
  • Heat-Shock Proteins
  • Immunoglobulins
  • Antigens, Protozoan

Grants and funding

This work was supported by Peer Reviewed Medical Research Program (PRMRP) Award #W81XWH-13-2-0098 (University of Miami PI NS) and #W81XWH-13-2-0099 (NMRC PI EV).